![]() |
市場調查報告書
商品編碼
1374886
全球患者返回電極市場 - 2023-2030Global Patient Return Electrodes Market - 2023-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
患者返回電極也稱為被動/板電極、電路板、接地電極(墊)和分散電極。其寬闊的表面可降低電流密度,在電外科手術期間安全地阻止電流流經患者身體,並避免燒傷。此電極板可以向系統發出訊號以增強安全性,而無需完全連接到患者。導電蓋由鋁製成,電阻低,無毒、不致敏、不刺激皮膚。
心血管手術數量的增加預計將推動未來幾年全球市場的成長。根據英國心臟基金會2022 年1 月的更新,截至2021 年11 月底,有近284,000 人正在等待時間敏感的心臟手術和其他心臟手術。由於患者返回電極用於心血管手術,預計將提振全球市場預測期內的成長。此外,壽命健康系統報告稱,美國每年進行超過 50 萬例心臟直視手術,包括主動脈或心臟本身的複雜手術以及冠狀動脈繞道手術。
此外,癌症、糖尿病和神經系統疾病等其他慢性病盛行率的上升預計也將促進預測期內全球市場的成長。
市場產品召回預計將阻礙預測期內的全球市場成長。例如,美國食品藥物管理局(FDA) 於6 月1 日將Megadyne(J&J Ethicon 品牌)召回的MEGA 2000 和MEGA 軟可重複使用患者返回電極列為I 類。此次召回影響3 月11 日期間分發的21,200 台設備、2021 年和 2023 年 5 月 9 日在美國。此外,與產品相關的問題以及其他因素也阻礙了全球市場的成長。
Patient return electrodes are also referred to as passive/plate electrodes, circuit plates, grounding electrodes(pad), and dispersive electrodes. Its broad surface decreases current density, safely stems current via the patient's body during electrosurgery, and averts burns. This electrode plate can signal the system to enhance safety without being completely connected to the patient. The conductive cover is constructed from aluminum, which has low resistance and is non-toxic, non-sensitizing, and non-irritating to the skin.
The increasing number of cardiovascular surgeries is expected to drive the global market growth in the coming years. According to the British Heart Foundation's January 2022 update, nearly 284,000 people were waiting for time-sensitive heart operations and other heart procedures by the end of November 2021. Since patient return electrodes are used in cardiovascular surgeries, this is expected to boost the global market growth during the forecast period. Additionally, the Lifespan Health System reports that over 500,000 open heart procedures are performed annually in the United States, including complex procedures for the aorta or the heart itself, and coronary artery bypass.
Moreover, the rising prevalence of other chronic conditions such as cancer, diabetes, and neurological disorders among others is also expected to contribute to the global market growth during the forecast period.
The market product recalls are expected to hamper the global market growth during the forecast period. For instance, the U.S. Food and Drug Administration (FDA) has classified Megadyne's (a J&J Ethicon brand) recall of MEGA 2000 and MEGA soft reusable patient return electrodes on June 1 as Class I. The recall affects 21,200 devices that were distributed between March 11, 2021, and May 9, 2023, in the United States. Further, problems associated with the product among other factors are also hampering the global market growth.
The global patient return electrodes market is segmented based on type, application, end user and region.
Electrotherapy is utilized for the treatment of neurological, muscular, or muscle-nerve conditions that induce pain. Electrotherapy can be advantageous in individuals encountering extreme sensitivity, numbness, or defects in back muscles. The growing cases of neurological, muscular, or muscle-nerve conditions are expected to boost the segment growth thereby dominating the global market during the forecast period. For instance, according to the National Safety Council of the United States in 2021, it is assessed that approximately 3.2 million individuals were treated in emergency units for injuries concerning sports and recreational tools in the United States in 2021.
Moreover, according to the Alzheimer's Association Alzheimer's Disease Facts and Figures 2022, Alzheimer's is additionally predominant in individuals past 65 years of age. Further, the WHO data also informed that the number would surpass 82 million by 2030. This growing load of nervous system diseases is expected to propel the demand for electrotherapy.
The North American market for patient return electrode is expected to dominate the global market during the forecast period owing to the increase in ambulatory surgeries and surgical centers. For instance, in the US, six out of ten adults suffer from chronic conditions, according to the Centers for Disease Control and Prevention (CDC), with the increasing number of ambulatory surgery centers, there is likely to be a greater number of open surgeries, which will in turn increase the demand for devices used for open procedures including patient return electrodes. Additionally, there has been a 2.1% increase in the number of Ambulatory Surgery Centers enterprises in the US as of 2023, with the number of firms expected to continue to rise.
Further, the presence of key market players holding majority of market share, growing awareness regarding chronic conditions and investments are also expected to contribute to the regional market growth during the forecast period.
The global market for patient return electrodes has been negatively impacted by the COVID-19 pandemic. During the outbreak, a large number of elective surgeries were either suspended or terminated, which led to a decrease in demand for these devices. For example, in order to optimize resources and address the unique needs of both the general population and healthcare systems, the FIGO and Minimal Access Surgery (MAS) board recommended suspending elective and non-urgent surgeries based on the health needs of each country and the response capacity of each healthcare system.
The major global players in the market include: Medtronic, CONMED Corporation, Ethicon, Inc., Bowa-Electronic Gmbh & Co. Kg, 3m, Erbe Elektromedizin Gmbh, Utah Medical Products, Inc., Baisheng Medical Co., Ltd., Xodus Medical Inc. And Eakin Surgical among others.
The global patient return electrodes market report would provide approximately 61 tables, 57 figures and 182 pages.
LIST NOT EXHAUSTIVE